Publications by authors named "Giovanni Sortino"

Claim this Profile
S
Stereotactic Radiotherapy in Early-Stage Breast Cancer in Neoadjuvant and Exclusive Settings: A Systematic Review.
Antonio Piras, Antonella Sanfratello, Luca Boldrini, Andrea D'Aviero, Gianfranco Pernice, Giovanni Sortino

Oncol Res Treat· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Prospective Observational Study on the Structuring Process and Implementation of a Large Regional, Inter-hospital, Virtual Multidisciplinary Tumor Board on Prostate Cancer.
Maria Rosaria Valerio, Vincenzo Serretta, Demetrio Arico, Ivan Fazio, Vincenzo Altieri, Giovanni Sortino

Anticancer Res· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bullous pemphigoid and radiotherapy: Case report and literature review update.
Antonio Piras, Bruno Fionda, Antonella Sanfratello, Andrea D'Aviero, Giovanni Sortino

Dermatol Reports· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The comparison of outcomes from tyrosine kinase inhibitor monotherapy in second- or third-line for advanced non-small-cell lung cancer patients with wild-type or unknown EGFR status.
Giuseppe Bronte, Tindara Franchina, Massimiliano Alù, Giovanni Sortino, Claudia Celesia

Oncotarget· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New findings on primary and acquired resistance to anti-EGFR therapy in metastatic colorectal cancer: do all roads lead to RAS?
Giuseppe Bronte, Nicola Silvestris, Marta Castiglia, Antonio Galvano, Francesco Passiglia, Giovanni Sortino

Oncotarget· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Monoclonal antibodies for the treatment of non-haematological tumours: update of an expanding scenario.
Giuseppe Bronte, Giovanni Sortino, Francesco Passiglia, Sergio Rizzo, Francesca Lo Vullo

Expert Opin Biol Ther· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of targeted therapy for gastrointestinal tumors.
Christian Rolfo, Giuseppe Bronte, Giovanni Sortino, Konstantinos Papadimitriou, Francesco Passiglia

Expert Rev Gastroenterol Hepatol· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunotherapy: is a minor god yet in the pantheon of treatments for lung cancer?
Christian Rolfo, Giovanni Sortino, Evelien Smits, Francesco Passiglia, Giuseppe Bronte

Expert Rev Anticancer Ther· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunotherapy for recurrent ovarian cancer: a further piece of the puzzle or a striking strategy?
Giuseppe Bronte, Giuseppe Cicero, Giovanni Sortino, Gianfranco Pernice, Maria Teresa Catarella

Expert Opin Biol Ther· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Monoclonal antibodies in gastrointestinal cancers.
Giuseppe Bronte, Giuseppe Cicero, Stefania Cusenza, Antonio Galvano, Emmanuela Musso, Giovanni Sortino

Expert Opin Biol Ther· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predicting efficacy and toxicity in the era of targeted therapy: focus on anti-EGFR and anti-VEGF molecules.
Michele Caraglia, Daniele Santini, Giuseppe Bronte, Sergio Rizzo, Giovanni Sortino

Curr Drug Metab· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis